article Open AccessTop 1% cited
Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in Type 2 (non-insulin-dependent) diabetic patients
Diabetologia · 1993 · Vol. 36(8) · pp. 741–744
Michael A. Nauck✉(University of Göttingen)N. Kleine(Diabeteszentrum Bad Lauterberg)C. �rskovJens J. HolstB. Willms(Diabeteszentrum Bad Lauterberg)W. Creutzfeldt(University of Göttingen)
Diabetes Treatment and ManagementDiabetes Management and ResearchMetabolism, Diabetes, and CancerInternal medicineEndocrinologyInsulinIncretinGlucagon-like peptide-1GlucagonBasal (medicine)Gastric inhibitory polypeptideMetforminMedicine
MeSH terms
AdultBlood GlucoseDiabetes Mellitus, Type 2Glucagon-Like PeptidesFastingFemaleGlucagonGlycated HemoglobinHumansHyperglycemiaHypoglycemic AgentsInfusions, IntravenousKineticsMaleMiddle Aged
Funding
- Sundhed og Sygdom, Det Frie Forskningsråd
- Deutsche Forschungsgemeinschaft
- Novo Nordisk
- Novo Nordisk Fonden
- Medical Research Council
Citations
1,087
FWCI
11.64
field-weighted impact
References
15
Percentile
99%
vs. same field & year
Citations per year
Cited by
Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans
American Journal of Physiology-Endocrinology and Metabolism · 1997 · 816 citations
Effects of Exenatide (Exendin-4) on Glycemic Control and Weight Over 30 Weeks in Metformin-Treated Patients With Type 2 Diabetes
Diabetes Care · 2005 · 1,553 citations
The Glucagon-Like Peptides
Endocrine Reviews · 1999 · 1,021 citations
Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2
American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 1999 · 526 citations
Appetite control
Journal of Endocrinology · 2005 · 428 citations
The incretin system and its role in type 2 diabetes mellitus
Molecular and Cellular Endocrinology · 2008 · 509 citations
The Physiology of Glucagon-like Peptide 1
Physiological Reviews · 2007 · 3,192 citations
Therapeutic potential of GLP-1 for treatment of diabetes
International journal of applied research · 2015 · 0 citations
References
Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.
Journal of Clinical Investigation · 1993 · 1,635 citations
Related articles
Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.
Journal of Clinical Investigation · 1993 · 1,635 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.